Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies

Journal of Virology

Volumn 75, Issue 10, 2001, Pages 4570-4583

  Leroux, C ^a   Craigo, J K ^a   Issel, C J ^a   Montelaro, R C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 90; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ARTICLE; EQUINE INFECTIOUS ANEMIA VIRUS; GENETIC VARIABILITY; HORSE; HOST RESISTANCE; IMMUNOREACTIVITY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; VIRUS VIRULENCE;

ACUTE DISEASE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CHRONIC DISEASE; DISEASE PROGRESSION; DNA, VIRAL; EQUINE INFECTIOUS ANEMIA; EVOLUTION, MOLECULAR; GENOME, VIRAL; GLYCOPROTEINS; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID; TIME FACTORS; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIREMIA;

EID: 0035027217     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.10.4570-4583.2001     Document Type: Article

References (34)

1. Fidelity of DNA synthesis exhibited in vitro by the reverse transcriptase of the lentivirus equine infectious anemia virus
2. Detailed mapping of the antigenicity of the surface unit glycoprotein of equine infectious anemia virus by using synthetic peptide strategies
3. Envelope sequence variation, neutralizing antibodies, and primate lentivirus persistence
4. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
5. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation
6. HIV population dynamics in vivo: Implications for genetic variation, pathogenesis, and therapy
7. Lentivirus envelope sequences and proviral genomes are stabilized in Escherichia coli when cloned in low-copy-number plasmid vectors
8. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats
9. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process
10. Immune responses and viral replication in inapparent carrier ponies inoculated with equine infectious anemia virus
11. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids
12. In vivo replicative status and envelope heterogeneity of equine infectious anemia virus in an inapparent carrier
13. Genetic analysis of viral variants selected in transmission of human immunodeficiency viruses to newborns
14. Genomic heterogeneity of small ruminant lentiviruses: Existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats
15. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony
16. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus
17. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies
18. Equine retroviruses
19. Endothelial cell infection in vivo by equine infectious anaemia virus
20. Antigenic variation and lentivirus persistence: Variations in envelope gene sequences during EIAV infection resemble changes reported for sequential isolates of HIV
21. Course and extent of variation of equine infectious anemia virus during parallel persistent infections
22. Fidelity of HIV-1 reverse transcriptase
23. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus
24. A role for carbohydrates in immune evasion in AIDS
25. The accuracy of reverse transcriptase from HIV-1
26. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1
27. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS
28. Identification of hypervariable and conserved regions in the surface envelope gene in the bovine lentivirus
29. Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein
30. Codon-substitution models for heterogeneous selection pressure at amino acid sites
31. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse
32. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: Insertions/duplications at the principal neutralizing domain